分子诊断量身定制个性化癌症治疗 - - 瘤学家的观点
Jakob M Riedl1, Florian Moik1, Tamara Esterl1
1Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Virchows Archiv : an international journal of pathology
|November 20, 2023
概括
精密瘤学通过针对特定的基因变异提供个性化癌症治疗. 克服临床相关性,异质性和实施方面的挑战是扩大患者从这个不断发展的领域中获益的关键.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 个性化医学和向治疗正在改变医疗瘤学.
- 分子诊断和了解癌症病理生理学识别导致癌症的遗传变化.
- 药物开发现在允许直接干扰特定的分子通路.
研究的目的:
- 审查癌症不可知精度瘤学的现状.
- 讨论分子瘤板和个性化癌症治疗的局限性.
- 为准确瘤学的未来发展提供前景.
主要方法:
- 关于精确瘤学的当前文献的综述.
- 讨论临床实施和分子解释方面的挑战.
- 探索未来的方向,如功能评估和液体活检.
主要成果:
- 精密瘤学代表了向分子向的,癌症类型的无神论疗法的范式转变.
- 仍然存在重大障碍,包括评估临床相关性,管理瘤异质性和实际实施.
- 未来的发展可能涉及功能评估和液体活检,以获得全面的遗传信息.
结论:
- 精确瘤学具有很大的前景,但需要解决关键局限性,以获得更广泛的患者利益.
- 分子瘤板和液体活检等先进诊断对于推进个性化癌症护理至关重要.
- 对功能评估和纵向监测的持续研究将完善个性化癌症治疗.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer
48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376


